Defective caspase-3 relocalization in NSCLC cells contributes to resistance against DNA-damage-induced apoptosis, emphasizing the importance of targeting apoptotic pathways to counteract this resistance (56). This evidence concerns the gene CASP3 and non-small cell lung carcinoma.